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Introduction
The history of immunology has attracted the attention of a number of historians
in recent years.' The results oftheir researches have yielded a wealth ofinsights into
technical and disciplinary developments. These works have concentrated, however,
on the elucidation of the immune mechanism, studies of autoimmunity and work
on viral and bacterial diseases. The notable absence from this historiography is the
immunology of the protozoan and metazoan parasitic infections that, whilst major
sources of suffering and mortality, have often been marginalized into the concerns
of tropical medicine and public health. Issues of parasitism, howeve mark one of
the closest loci for the interaction ofmedical and veterinary concerns. Many parasites
of man such as Taenia saginata and Trichinella spiralis are believed to be contracted
from common farm animals and their meat products. The history of science within
the veterinary tradition is little known. Further, the relations between medical and
veterinary knowledge in thelate twentieth century remain to beelucidated:frotozoah
diseases are also commonly found in other animal populations. For example, bird
malaria has been used as a research model since the 1890s.' One of the first
demonstrations of arthropod transmission of pathogenic protozoa was that of
Babesia bigemina by the cattle tick, Boophilus annulatus.3 An historical approach to
the study of this subject can be used to elucidate interactions between issues of
human and animal health. Further, the history of parasite immunology provides a
useful insight into the relations between twentieth-century medical science and many
of the most pernicious diseases of the third world.
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The absence of parasite immunology in the historiography of medicine reflects a
similar absence in the practice of science. Whilst immunological approaches to the
study of viral and bacterial disease have been popular throughout the twentieth
century, this has not been reflected in work on metazoan and protozoan infections.
The eventual development of parasite immunology as an area of study occurred
through varying disciplinary associations in different regions. For example, in the
UK, parasite immunology developed through an affiliation with malaria therapy,
tropical medicine, veterinary research, immunology and parasitology.4 The limited
influence of tropical medicine in the post-war period, and its concentration within
two relatively small institutions in London and Liverpool, ensured that even strong
links to this discipline offered only restricted opportunity for the development ofthe
field. Whilst links to veterinary research can be shown to have been important,
veterinary research in the UK has remained remarkably limited.
The development of parasite immunology in the United States was the product
of considerably different economic considerations and disciplinary relations. In the
UK domestic malaria has caused little concern in the twentieth century except during
the two World Wars,5 and nematode infections have been only marginal concerns.
Conversely, in the USA, the existence in some states ofhyperendemic hookworm as
well as endemic malaria, coupled with military concerns regarding parasitic disease
in South America, facilitated the development ofparasite immunology in association
withpublichealthaswellastropicalmedicine. Ininter-warAmerica, thephilanthropic
activities of the Rockefeller Foundation facilitated the development of an extensive
parasite immunology network.6 Not only was a great deal ofresearch funded by the
Foundation but many of the earliest parasite immunologists were trained at the
Johns Hopkins University School of Hygiene and Public Health. Opened in 1916
with Rockefeller Foundation sponsorship, this school was one of "the principal
centres for the Rockefeller Foundation's International Health Board's campaign for
world-wide improvements in public health through applied medical science and
education".7 As Ilana Lowy has noted, the school functioned essentially as a training
institution for Rockefeller personnel.8 As a product ofits agenda to apply the most
advanced science to issues ofpublic health, the Foundation provided opportunities
for initial training in parasite immunology and a subsequent career structure.
Despite these developments in the UK and USA, in 1964 a World Health
Organization expert Committee on Immunology and Parasitic Diseases concluded
in its report that research activities relating to the immunology of parasitic diseases
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were extremely limited. Contemporary immunologists, it would seem, had little
insight into the problems faced by parasitologists.9
In subsequent years, the WHO launched an international scheme ofImmunology
Research and Training Centres (WHO IRTCs). In this paper I will show that these
IRTCs represented a deliberate attempt to redefine the discipline of immunology
thus incorporating WHO concerns regarding infectious diseases ofparasitic etiology.
The Centres were mostly located within "tropical" countries and were thus brought
into proximity with indigenous parasitic diseases. However, the placing of centres
was not based on a formal policy. Instead, the WHO looked for pre-existing facilities
combined with an enthusiastic immunologist or sympathetic administration. Thus,
as well as the politically attractive centres in Africa, Asia etc., the WHO found it
convenient to found centres in Europe and Australasia. As a result of varying
funding arrangements, WHO control ofthe centres was far from total. Despite this,
Geneva-based WHO staff were active in influencing the research activities of the
three Centres studied here. It can be seen that the WHO IRTCs at Ibadan,
Sao Paulo and Lausanne functioned as research and training centres in parasite
immunology.
WHO Research
Involvement in research was incorporated within the WHO's constitution. Under
this remit the new Organization was to "promote and conduct research in the field
ofhealth"."0Despite this obviousconstitutionalmandate, research was notconsidered
to be a major responsibility ofthe Organization.1' Its initial focus had been on often
large-scale field work projects, most notably the malaria eradication scheme. By
1960 the annual malaria account ofthe WHO exceeded the regular budget by almost
US$2 million.'2 Even with such massive investment, the restricted success of the
malaria programme must have highlighted the limitations in contemporary tech-
nology and knowledge. At the Eleventh World Health Assembly in Minneapolis in
June 1958, however, the American delegation offered a special contribution of
$300,000 to facilitate a study "ofthe role ofWHO in research and the ways in which
the Organization might assist more adequately in stimulating and co-ordinating
research and developing research personnel".'3 A subsequent resolution was passed
(WHA 11.35)14 which accepted the donation and instructed the Director to prepare
the suggested report for presentation at the Twelfth World Health Assembly and the
twenty-third meeting of the executive board.
'Immunology andparasitic diseases, WHO and Bridie Andrews (eds), Western medicine as
Technical Report Series, No. 315, Geneva, WHO, contested knowledge, Manchester University Press,
1965, pp. 5-6. 1997, pp. 24-45, on p. 29.
10 Thefirst ten years ofthe World Health 13 The medical research programme ofthe
Organization, Geneva, WHO, 1958, p. 460. WHO 1958-1963, Geneva, WHO, 1964, p. 1.
"'Twelfth World Health Assembly, Geneva, "Handbook of resolutions and decisions of
12-29 May 1959', Official records ofthe WHO, the world health assembly and the executive
No. 95, Geneva, WHO, 1959, p. 505. board, 1948-1972, vol. 1, Geneva, WHO, 1973,
12Sung Lee, 'WHO and the developing world: p. 24.
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At the Twelfth World Health Assembly in Geneva in 1959, the Director General
provided an account of the history of WHO medical research:
Research is a part of the constitutional mandate of WHO, but relatively little emphasis was
put on this function at the outset. The core ofthe Organization's early programmes consisted
ofcertain central functions ofpublic health importance and direct assistance to governments
in the control ofparticular mass diseases, mostly communicable. Nevertheless, as early as the
Second World Health Assembly the principles that should govem future WHO research
activities were considered, because it was realized that the scientific knowledge available was
not adequate to secure the success of the disease control programmes ... Thus, in the course
of the years, the Organization gradually developed some research activities, particularly in
the field of communicable diseases.'5
When contrasted with this utilitarian tradition, the research programme set out in
the American-funded report marked a significant change. Central to this transition
was the demolition of boundaries between "fundamental" and "applied" research,
with such categories condemned as "artificial".'6 This reconceptualization of all
research work as part of "a continuous spectrum" allowed for a massive increase in
the research remit of the Organization: in the future almost all medical science was
to be considered a valid activity for WHO involvement. The objectives of the WHO
Intensified Medical Research Programme were the stimulation and initiation ofnew
research, as well as the promotion, organization and co-ordination of existing
research.'7 In particular, the programme was to support the expansion of work in
"special world health problems", whilst "advancing medical research generally".'8
While the philosophy of the new project outlined in the Director-General's report
clearly provided for a near universal research agenda, a number of specific research
areas were given high priority in the initial year. The communicable diseases were
acknowledged as being the "greatest hazard to the health ofman".'9 These infectious
diseases were central to the culture of the Organization and had formed the core of
WHO interests since its founding. Conversely, it was recognized that in many of
the developed countries the "chronic" (non-infectious) conditions were "of prime
importance".20 It was initially estimated that the cost of the programme would be
as high as $2,200,000 for the first year alone.2' To facilitate such great expenditure
an account was opened for the receipt of voluntary donations.22
Consequently, from around 1960, the medical research programme of the WHO
was intensified. As the WHO's funds were relatively limited, the Organization
attempted to stimulate and control research through the provision of training and
equipment rather than simply funding limited research projects. Whilst the research
programme was broad, the WHO tradition of work on communicable diseases
continued to dominate, with this area initially accounting for over 50 per cent of
the expenditure.23 Of the communicable diseases included, those of viral etiology
15 Official Records ofthe World Health 21 Ibid., p. 518.
Organization, No. 95, Geneva, WHO, 1959, p. 27. 22See Resolution WHA 12.17 parts 8 and 9 in
16Ibid., p. 505. WHO, Handbook ofresolutions and decisions of
Ibid., p. 506. the World Health Assembly and Executive Board
I8Ibid., p. 506. 1948-1972, vol. 1, Geneva, WHO, 1973, p. 25.
'9Ibid., p. 618. 23 Official records ofthe World Health
20Ibid., p. 518. Organization, No. 131, Geneva, WHO, 1964, p. 6.
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received the greatest research funding, but the parasitic diseases received between
US$200,000 and $300,000 per annum between 1961 and 1963. They were, therefore,
a significant part ofthe new programme.24
The World Health Organization Immunology
Research and Trainiing Centres
The WHO's involvement in disciplinary immunology was initiated by a series of
five meetings of "experts". Held in Geneva between 22 January and 9 June 1962,
these meetings consisted of the Scientific Groups on Immunoprophylaxis and Im-
munotherapy; Immunopathology; Immunochemistry; Tissue Antigens and Trans-
plantation; and the Research Programme in Immunology. The deliberations ofthese
five meetings were published as a technical report under the title Research in
Immunology,25 which, it was claimed, provided a "presentation of the key problems
in immunology".26 These meetings were essentially a consultation exercise designed
to outline appropriate research areas for WHO intervention. Such interest was based
not only on a belief that "immunology [was] one of the fastest growing fields of
medicine" but also the notion that "its ramifications are extending into many other
fields, revivifying research in a host of subjects".27 As such, immunology was to be
of "central importance"28 to the Organization's medical research programme. The
report of the Scientific Group on Immunoprophylaxis and Immunotherapy ac-
knowledged the contemporary importance of the development of "Dictol", an
irradiated vaccine against the nematode pathogen Dictyocaulus viviparus, and sub-
sequent research on anti-parasitic vaccines at the Glasgow Veterinary School.29
While the first four of these meetings outlined the contemporary issues in im-
munology research, the fifth on the "Research Programme in Immunology" set out
largely to provide a research agenda. Surprisingly, the recommendations of the
meeting did not concentrate primarily on specific technical problems appropriate for
WHO involvement. Instead, the delegates elaborated upon a training and service
role which the WHO might profitably fulfil:
Highest priority should be given to the setting up of long-range education and training
programmes in Africa, Asia and South America. These should involve the establishment of
functioning units in immunology on a long term basis (at least five years). Arrangements
should be made for a senior person to spend three months a year for several successive years
in a university or medical school in an area selected for this programme, to conduct courses,
carry out research, and train collaborators from the area. During the three-month period
plans for continued activity for the rest of the year could be made and carried out by the
other workers, supplemented, if possible, by a suitably qualified junior assistant who would
24 expenditure on the parasitic diseases 26Ibid., p. 4.
quoted is calculated by adding the amount spent 27Ibid., p. 4.
on "parasitic diseases" to the amount spent on 28Ibid., p. 4.
malaria. See WHO, op. cit., note 11 above, pp. 29Ibid., pp. 9-10.
9-11.
25Research in immunology, WHO Technical
Report Series, No. 286, Geneva, WHO, 1964.
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come for a longer period. Many of the problems of the developing countries can best be
solved by groups working on the spot.30
The slightly patronizing nature ofthese proposals-note the developing countries
were not considered able to provide even ajunior assistant-was possibly a product
of the Western dominance of the committee.3' Immunology, perceived as a modern,
highly technical Western construct, would be transferred to Africa, Asia and South
America by the movement ofWestern personnel.
The service functions proposed in the report32 of the Scientific Group included
the provision of an information facility listing the availability of reagents and
experimental animals. Also the Organization's leading role in the standardization of
nomenclature and serological methodology was outlined. Finally, reference centres
should be founded "for the examination, storage, exchange, and distribution of sera
from patients with auto-allergic diseases, specific plasma protein deficiencies and
sensitivities to drugs and other substances".33 The committee concluded with a list
of only seven research activities in which the WHO might fruitfully be involved.
These suggestions varied from the provision of assistance in field trials of vaccines
to surveys of human immunoglobulin levels, with an emphasis on the study of
autoimmune conditions. The role proposed for the Organization in the study ofthe
immunology of communicable diseases was to be parasitological research:
Investigations should be made into the antigenic composition ofprotozoa and helninths and
the immunological mechanisms involved in resistance to or recovery from infection by these
agents. Such investigations are potentially fruitful both for epidemiological studies and for
the development of practical immunization procedures.34
As a result of this recommendation, a WHO expert committee on "Immunology
and Parasitic Diseases" was convened at Ibadan in 1964.35 The committee consisted
of such eminent immunologists as J H Humphrey and I Riha, as well as notable
parasitologists such as E J L Soulsby and W P Rogers. The outstanding position
of the Glasgow Veterinary School, whose researchers had recently developed a
commercially successful irradiated vaccine to lungworm in cattle, was acknowledged
bythemembership on thiscommittee ofI McIntyre, Professor ofVeterinary Medicine
at Glasgow.36
30Ibid., p. 79. 36Members of the committee: D A L Davies
31 The Scientific Group on the Research (Medical Research, Victoria Hospital, Sussex), F
Programme in Immunology consisted of Sir J Dixon (Experimental Pathology, Scripps Clinic,
Macfarlane Burnet (Australia), Dr A H Coons USA), J C Edozien (Medical School, University
(USA), Dr J H S Gear (South Africa) and Dr P of Ibadan, Nigeria), J H Humphrey
Grabar (France). (Immunology, NIMR, UK), I McIntyre
3 For full details of the proposals, see (Veterinary Medicine, Glasgow, UK), I Riha
Research in immunology, op. cit., note 25 above, (Microbiology, Czechoslovak Academy of
pp. 80-1. Science, Czechoslovakia), W P Rogers (Zoology,
33Ibid., p. 81. University ofAdelaide, Australia), E J L Soulsby
34Ibid., p. 83. (Parasitology, Veterinary Medicine, University of
3 The proceedings of this meeting were Pennsylvania, Philadelphia).
published as Immunology andparasitic diseases,
WHO Technical Report Series, No. 315, Geneva,
WHO, 1965.
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The committee lamented the limitations ofthe contemporary parasite immunology
tradition:
The close contact between immunology and bacteriology since the beginning of the century
has not been paralleled by similarly close contact between immunology and parasitology ...
It is hoped that the report, even though it discloses the wide gaps in present knowledge of
the immunology ofcertain parasitic diseases, will nevertheless serve to provide immunologists
with an outline of some of the problems with which parasitologists are faced, and induce
more parasitologists to consider the possibility of a fruitful approach to these problems in
terms of immunological concepts.37
Subsequently, the report consisted largely of a review of the current status
of parasite immunology. The final section recommended important research and
anticipated the role that the WHO Immunology Research and Training Centres were
to play in the promotion of parasite immunology:
The committee gave high priority to the programme for WHO Immunology Training and
Research Units in developing countries, one example being the newly organized prototype
unit at the University of Ibadan, Nigeria. The programme is based on providing training in
research and by bringing scientists to the developing countries, in order to avoid the ill-effects
due to geographical dislocation of the scientist in training, which too often include failure to
return to his native country.
The programme oftraining is designed to give broad modern theoretical and experimental
knowledge ofresearch trends and techniques, with a view to stimulating creativity and a level
oftechnical skill suitable for the most advanced attack on fundamental and practical problems
of medicine and allied sciences.
In addition, the eminent scientists who will undertake the training and research will be
brought at the same time into direct contact with the pressing health problems of the
developing countries, inter alia the parasitic diseases. This can be expected to increase the
number of immunologists who will take up problems directly or indirectly related to the
parasitic diseases.38
From the earliest founding ofthe Centres, therefore, it was implied that the WHO
Immunology Research and Training Centres were to have a role not only in the
promotion of immunology but also in the defining of immunology's disciplinary
boundaries. The marginalization ofparasitic disease research into the limited speci-
alityoftropicalmedicine(especiallyinEurope),withitsattendantepidemiological and
entomological traditions and limited research base, had located parasite immunology
within a disciplinary vacuum. The founding ofWHO IRTCs was a conscious attempt
to redress an absence in both the parasitology and immunology traditions.
WHO IRTC, Ibadan, Nigeria
The early records of the World Health Organization Immunology Research and
Training Centre, at the University of Ibadan39 have not been available. The official
3 Immunology andparasitic diseases, op. cit., Power, Tropical medicine in the twentieth
note 35 above, pp. 5-6. century: a history of the Liverpool School of
38Ibid., p. 64. Tropical Medicine 1898-1980, London, Kegan
3 For further details of the progressive Paul, 1999.
nature of the University of Ibadan see, Helen
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agreement between theWHO andtheUniversitywhichprovidedfortheformalization
ofthe funding and administration ofthe Centre was not signed until the autumn of
1966.40 However, there is some evidence that activities in Ibadan pre-dated the official
agreement, as Dr I Riha of the Czechoslovakian Academy of Science appears to
have delivered a course there in 1965.4' The objectives ofthis unit as formally agreed
between the WHO and the University were twofold. It was to provide a four to six
month course for African postgraduate students and also carry out a research
programme as agreed by the Department of Chemical Pathology, University of
Ibadan, and the World Health Organization.42
Attracting eminent Western scientists to Africa in the 1960s was predictably
difficult. In particular, the social and political instabilities of Nigeria made the
country especially unattractive. With the conclusion of Dr Riha's brief consultancy
in 1965 the Centre was left without a senior scientist. The only trained Western
member ofstaffwas Ada E Bezer, an American laboratory technician. Despite these
unfortunate circumstances, Bezer found herself able to teach laboratory methods,
and give a few basic lectures to Gabriel Otiko, her African counterpart, as well as
a number ofundergraduates.43 Research at the Centre continued despite the absence
of a research scientist. By November 1967, Bezer had begun a project to prepare
specific antiserum to African IgM under David Rowe ofthe University ofLausanne.
Gabriel Otiko was continuing his training in basic immunological techniques whilst
also beginning research on antibody production to foetal protein under Hylton
McFarlane of Ibadan University's Department of Chemical Pathology."
It was some three years before a temporary solution to the staffing crisis was
found. In January 1968 Dr Vashek Houba,45 an immunologist and rheumatologist,
arrived on temporary secondment from the Czechoslovakian Academy of Science.
Whilst in Ibadan, Houba was to take on the role ofWHO consultant in immunology
and Temporary Director of the Centre.' With his arrival, the research profile ofthe
Centre was to change. Houba was not, however, the instigator of this change. As
early as 1966, M W Turner of Great Ormond Street Hospital, London, had visited
the Centre in the capacity of Temporary Adviser to the WHO.47 Turner was asked
to "investigate the technical arrangements necessary for the further investigation of
the postulated role of antigen excess soluble complex in the Plasmodium malariae
nephrotic syndrome".48 Upon his return to the UK, Turner had begun a collaborative
project on this subject with R G Hendrickse, then Professor of Paediatrics at the
4World Health Organization Archive, 4WHO Archive, Letter from A E Bezer to Z
Geneva, (hereafter WHO Archive), 'Agreement Trnka, 13 Nov. 1967, 15/286/4(A) and 'Quarterly
between the University of Ibadan, Ibadan, field report', 13 Nov. 1967, 15/286/4(A).
Nigeria and WHO on the establishment of a 'WHO Archive, 'Quarterly field report', 13
WHO Immunology Research and Training Nov. 1967, 15/286/4(A).
Centre, September and October 1966', WHO I5/ 45Houba is occasionally called Vaclav Houba
286/4(A). in correspondence.
41 WHO Archive, 'Immunology course " WHO Archive, 'Quarterly field report', Jan.
programme', accredited to Dr I Riha and dated 1968, 15/286/4(A).
1965, 15/286/4(A). 47WHO Archive, 'Visit to University College
42 WHO Archive, 'Agreement between the Hospital, Ibadan', 18-23 Dec. 1966, 15/286/4(A).
University of Ibadan and the WHO', I5/286/4(A). 48 Ibid.
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University ofIbadan.49 Turner and Hendrickse werejoined in this work by Professor
John Soothill of Great Ormond Street Hospital, who also visited Ibadan as a
Temporary Adviser to the WHO in 1966.50 With the arrival of a full-time Director,
the staffofthe Immunology Section ofthe WHO were keen to "overcome the service
type small project mentality" which the Centre was perceived to have.5' It was
proposed that a "stable research project"52 was needed to achieve this, and the
immunology of malaria, with its WHO-inspired local tradition, was selected.53
Within three months, malarial immunology had begun at the Centre. Houba was
collaborating with Professor J B Lawson of the Department of Obstetrics and
Gynaecology, University College Hospital, Ibadan, on a project to study levels of
immunoglobulins in malarious pregnant women. Other research in the Centre
included a study ofantibody levels in trypanosomiasis infected cattle in collaboration
with the Veterinary Department of the University, and a small amount of work on
Houba's long-standing interest in immunoglobulins in meningitis.54 By June, the
studies ofpregnant women had been concluded and, along with Tony Allison ofthe
National Institute of Medical Research, UK, Houba had begun to study the role of
immune complexes in malaria nephrotic syndrome in children. Concurrently, studies
on trypanosomiasis in cattle continued along with a limited amount of work on
meningitis.55
With the impending conclusion of Houba's six-month consultancy the future of
the Centre and the continuation of its research activities again came under threat.
The difficulties of appointing a "Team Leader" to the Ibadan Centre were being
discussed betweentheAssistant-Director General oftheWHO andtheOrganization's
immunology section.56 The unpopularity of overseas work in the post-war period,
coupled with the buoyant market for medical scientists, ensured that appointing a
Western scientist of sufficient status to a post in Africa was difficult. Consequently,
it was hoped that Houba would apply for the permanent Directorship ofthe Centre
upon the conclusion ofhis consultancy.7 However, within three months ofhis arrival
Houba had expressed his wish to leave Africa.58 Nigeria was still experiencing the
ramifications ofcivil war and Ibadan was a tense place in which to live. The Houbas'
determination to leave Africa had been accentuated by a burglary whilst they were
at home, and the theft of the Centre's car.59 In an attempt to avert the impending
crisis, Hylton McFarlane wrote to Howard Goodman, the Chief of Immunology at
the WHO in Geneva. Formerly head ofclinical immunology at the National Institute
of Allergy and Infectious Disease, USA, Goodman was evangelical about the need
4 WHO Archive, Letter from M W Turner to Letter from Z Trnka to H C Goodman, 9 Feb.
R G Hendrickse, 30 Dec. 1966, 15/286/4(A). 1968, 15/286/4(A).
'WHO Archive, Letter from H C Goodman 5 WHO Archive, 'Quarterly field report', 9
to P M Kaul, 20 Oct. 1966, I5/286/4(A) April 1968, 15/286/4(A)
"' WHO Archive, Letter from Z Trnka to H C 5 WHO Archive, 'Quarterly field report', 7
Goodman, 9 Feb. 1968, 15/286/4(A). June 1968, I5/286/4(A).
52 Ibid. 56WHO Archive, Internal memo Z Trnka to
53Zdenek Trnka of the Immunology Division A M-M Payne, 24 July 1967, I5/286/4(A).
of the WHO suggested the research problems for 57 Ibid.
the Centre should be selected from the recent 58 WHO Archive, Letter from V Houba to H
report of the Scientific Group on the C Goodman, 23 July 1968, I5/286/4(A).
Immunology of Malaria. See WHO Archive, 59Ibid.
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for increased research into tropical disease. Subsequently, he was to promote and
direct the WHO's much more expansive tropical disease research and training
programme. The problem of appointing a Western Director, McFarlane believed,
could be circumvented by elevating the Centre to a Department of Immunology,
and thus attracting a Nigerian for the post.60
Ironically, it was civil and political unrest in Czechoslovakia that afforded a
solution. On 3 July 1968, Houba wrote to Goodman stating that his position as a
research scientist in Czechoslovakia had become untenable. This situation, he
explained, coupled with his satisfaction at the demonstration of immune complexes
in the glomeruli ofchildren suffering from malaria nephrotic syndrome, encouraged
him to apply for the permanent post of Director. His application was not un-
conditional: he would accept the post only if he was granted regular study trips to
European laboratories as well as home leave.6' Within threeweeks ofthis application,
news of Houba's appointment, apparently unchallenged, had reached Africa.62
The appointment of a permanent Director guaranteed the immediate future of
the Centre. With the recommencement of research activities early in 1969, the
parasitological focus of the Centre was secured. The early success of research on
malarial nephrotic syndrome, coupled with the accessibility ofsubjects in University
College Hospital (UCH), Ibadan, made this an obvious focus for the renewed
research effort.63 Houba and his collaborators in the Department of Paediatrics,
UCH, reviewed the results of the 1968 work and decided to continue the project:
(a) to include new patients into groups under observation;
(b) to repeat the renal biopsies in patients investigated in 1968 (e.g. after treatment) and;
(c) to evaluate the effect oftherapy.6'
Work on malaria nephropathy syndrome continued until the WHO's withdrawal
from the Centre, and its Africanization as a department of Ibadan University in the
summer of 1972. During the previous years this rich line ofresearch had led to many
of the Centre's most prestigious publications in journals such as the Lancet and
Clinical and Experimental Immunology.65 Other malarial immunology research at
the Centre included studies of soluble Plasmodium falciparum serum antigens in
collaboration with A I 0 Williams, a PhD student in the Department of Chemical
'WHO Archive, Letter from H McFarlane to 65Allison, et al., op. cit., note 63 above, pp.
H C Goodman, 17 June 1968, I5/286/4(A). 1232-8; A Adeniyi, R G Hendrickse and V
61 WHO Archive, Letter from V Houba to H Houba, 'Selectivity of proteinuria and response to
C Goodman, 23 July 1968, 15/286/4(A). prednisolone or immunosuppressive drugs in
62WHO Archive, Letter from A E Bezer to H children with malarial nephrosis', Lancet, 1970, i:
C Goodman, 13 Aug. 1968, 15/286/4(A) 644-8; V Houba, A C Allison, A Adeniyi and J E
63The earlier portion of this work was Houba, 'Immunoglobulin classes and complement
published as A C Allison, R G Hendrickse, G in biopsies of Nigerian children with nephrotic
M Edington, V Houba, S De Petris and A syndrome', Clin. Exp. Immunol., 1971, 9: 761-74;
Adeniyi, 'Immune complexes in the nephrotic R G Hendrickse, A Adeniyi, G M Edington, E F
syndrome of African children', Lancet, 1969, i: Glasgow, R H R White and V Houba, 'Quartan
1232-8. malarial nephrotic syndrome: collaborative
64WHO Archive, 'Quarterly field report', 22 clinicopathological study in Nigerian children',
May 1969, 15/286/4(A). Lancet, 1972, i: 1143-9.
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Pathology.' The other consistent research interest in the centre was the study of
antibodies in cattle and rabbits suffering from trypanosomiasis. This work was
conducted in collaboration with the veterinary department of the University and
members ofthe WHO Trypanosomiasis Project, Kenya.67 The work ofthe laboratory
was communicated not only through publications, but also through conference
presentations given by Houba,68 as well as the presence of Houba and associated
staff at WHO Scientific Group meetings.69
The research activities of the Ibadan Centre appear to have correlated well with
the objectives ofthe WHO Immunology Research and Training Programme. Despite
considerable effort and investment, the Centre's teaching programmes achieved only
very localized influence. At the initial meeting at which the roles of the IRTCs were
defined "prime emphasis" was placed "on the urgency and importance of training
immunologists".70 In subsequent negotiations between the University ofIbadan and
the WHO it had been agreed that the main vehicle for this training function would
be an annual four to six month course taught by the staff ofthe Centre, assisted by
a number of eminent visiting consultants.7' The course consisted largely of lectures
combined withpractical sessions andpractical demonstrations, andprovided a broad
introduction to the "basic" immunology of the day. The latter stages included a
research project and predictably this introduced the students to the parasitological
interests of the Centre's staff. Subsequently, a number of participants continued
research in parasite immunology upon completion of the course.72
At the African Centre, such "annual" courses were offered in 1965, 1968, 1969,
1970 and 1972. Whilst those for 1966 and 1967 had been cancelled due to the staffing
crisis outlined earlier, the 1971 course was abandoned because of the growing
frustration oftheWHO at the failure ofthis expensive programme to attract students
from outside Nigeria. Instead, it was decided that the money for that year could be
6 WHO Archive, 'Quarterly field report', 1
April 1971, 15/286/4(A). This work led to a
number ofpublications: V Houba and A I 0
Williams 'Soluble serum samples of Plasmodium
falciparum in Nigerians. I. Local incidence of
malarial soluble serum antigens and antibodies',
Afr J. med Sci., 1972, 3: 295-307; V Houba and
A I 0 Williams, 'Soluble serum antigens of P
falciparum in Nigerians. II. Immunochemical
studies', Afr. J. med Sci., 1972, 3: 309-17.
67WHO Archive, 'Quarterly field report', July
1970, 15/286/4(A).
68Houba was funded to travel to Britain in
1970 to present a paper titled 'Immunoglobulin
classes and complement in serial biopsies of
African children with nephrotic syndrome' at a
British Society for Immunology meeting in
London. Houba presented a further paper at the
Second International Congress on Immunology,
Brighton, July 1974.
69For example, at the Scientific Group on
Developments in Malaria Immunology at Geneva
23 April to 2 May 1975 Houba was a member of
the secretariat B 0 Osunkoya, Senior Lecturer in
immunology in the Department of Chemical
Pathology from 1970 and, after Houba's
departure, the Director of the re-named WHO
Collaborating Centre on Immunology Research
and Training, Ibadan, was Vice-Chairman of the
Scientific Group.
70Research in immunology, op. cit., note 25
above, p. 79.
7 Consultants included A Allison, A J S
Davies, J Sterlz, J Fahey, G Asherson and J
Holborow.
72 For example, A Williams wrote a PhD
thesis and numerous articles on malarial
immunology. Dr Esuroso collaborated on
trypanosomiasis work and Drs Abioye and
Ademola worked on amoebiasis and big spleen
disease.
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better spent by allowing Houba to travel to different African countries "to stimulate
interest in immunology and to assess candidates personally".73 Other activities in the
Centre included the supervision of undergraduate74 and postgraduate students.75
Professor Houba and Dr Osunkoya (Senior Lecturer in Immunology, Department
ofChemical Pathology)76 also lectured to medical students77 and from 1972 an MMed
course was delivered.78
The success of the teaching function of the Centre was considered to be limited.
The annual course attracted only a handful of applications and these were usually
frommembers ofIbadan University. Despiteconsiderable expenditureon recruitment
for the 1972 course only seven students attended, of whom four were Nigerians.79
The lack of influence ofthe teaching programme was a major factor in the decision
to transfer the Centre to local control at an early stage. In a 1971 memo titled the
'Future Existence ofWHO IRTC, Ibadan', Houba himself admitted that the Centre
"had trained a few West Africans from other countries but had achieved nothing
for East Africa".80 He concluded this memo by suggesting that the Centre be
transferred to the University of Ibadan and the WHO staff moved to Nairobi,
Kenya, to found an East African IRTC. The agreement between the WHO and the
University ofIbadanwasbroughtto anendin March 1972withanofficialexplanation
in terms of the professionalism of the University's staff:
This letter terminating the agreement with the University reflects our considered opinion that
a stage has been reached that the University ofIbadan has a professional immunological staff
fully qualified tocontinue research and training inimmunologywithout theconstant assistance
of a WHO team. I trust that this procedure will meet with your approval.8'
Such an explanation is congruent with earlier assertions that the WHO IRTCs
would eventually come under local control and persist as departments of im-
munology.82 Consequently, the termination of the agreement appears to have been
accepted without objection. The early transfer of the Nigerian Centre was largely
instigated bytheperceived failure oftheintended teaching programme. Subsequently,
the laboratory was renamed the WHO Collaborating Centre on Immunology Re-
search and Training, Ibadan, and was directed by B 0 Osunkoya. Under the new
73WHO Archive, Letter from H C Goodman
to Parker A Small, 1 Sept. 1970, I5/286/4(A).
74WHO Archive, 'Quarterly field report', 13
Nov. 1967, I5/286/4(A).
75For example, Dr G 0 Esuruoso, 'Cellular
pathology ofpathogenic trypanosomes', Dr A A
Abioye, 'Immunopathology of amoebiasis in
Ibadan' and Dr Sagoe, 'Tropical splenomegaly in
Ibadan'.
76 Dr Osunkoya transferred from the
Department of Pathology to the Department of
Chemical Pathology to take up the post of Senior
Lecturer in Immunology in 1970. WHO Archive,
'Quarterly field report', 14 Jan. 1971, 15/286/4(A).
77WHO Archive, 'Quarterly field report', 30
Oct. 1969, 15/286/4(A).
78 WHO Archive, 'Quarterly field report', 28
April 1972, I5/286/4(A).
79The seven students consisted of four
Nigerians, one Ugandan, one Kenyan and one
Tanzanian. WHO Archive, 'Quarterly field
report', 28 April 1972, 15/286/4(A).
80WHO Archive, Internal memo V Houba to
H C Goodman, 'Future existence ofWHO IRTC,
Ibadan', 18 Dec. 1971, I5/286/4(A).
81 WHO Archive, Letter from T A Lambo
(Acting Director-General, WHO) to G M
Edington (Acting Vice-Chancellor, University of
Ibadan), 1 March 1972, I5/286/4(A).
82H C Goodman, 'WHO: International
Research', World Health, June 1972: 20-5,
p. 20.
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directorship the malariology tradition of the Centre was continued.83 As proposed,
Houba moved to Nairobi, Kenya, where he founded and directed a new WHO
IRTC.84 At this location he continued his researches into malarial immunology
before expanding into trypanosomal research.
WHO IRTC, Sao Paulo, Brazil
Within months of the opening of the Ibadan Centre, negotiations had begun
regarding the opening of a similar enterprise in Sao Paulo.85 An established local
scientist, Otto Bier, had secured informal agreement for the provision offellowships
from the National Research Council ofBrazil, and assurances from universities and
research institutes that graduates ofsuch a Centre would be employable.86 By March
of 1967, the Centre87 had opened under the Directorship of Otto Bier at the Escola
Paulista de Medicina.88 In that same year, the Centre offered its first annual eight-
month course for postgraduates. Similar to the Ibadan course, the Sao Paulo
programme was taught by the resident staffand a number ofWestern consultants.89
The research carried out at the Centre between 1967 and 1968 correlated well
with the mechanistic focus ofthe contemporary American immunological tradition.
The structure and function of antibodies was central to this research programme,
whilst the effect of snake venom on the immune system received much interest. The
only significant disease-centred research in progress at this time was a number of
studies of the rare and little understood, fatal dermatological condition, pemphigus
foliaceus.9 Research in this early period was highly productive and led to many
publications in internationaljournals such as Immunology and the American Journal
ofEpidemiology.91
"Developments in malaria immunology, WHO
Technical Report Series, No. 579, Geneva, WHO,
1975, p. 4.
84Ibid.
85WHO Archive, Letter from H C Goodman
to M G Candau (Director-General, WHO), 22
Oct. 1965, 15/286/4(C).
16WHO Archive, Letter from H C Goodman
to Director-General, WHO, 22 Oct. 1965, 15/286/
4(C).
"The Sao Paulo IRTC is referred to both as
Center and Centre by different authors. For
continuity I have used the English spelling Centre
except where quoted.
88WHO Archive, Internal memo, Immunology,
Geneva, to Regional Director, American Regional
Office, 6 March 1967, 15/286/4(C).
89Consultants to the first course were R
Binagli (France), Byron Waksman (USA) and E
A Kabat (USA). WHO Archive, 'WHO
immunology research and training center:
calendar of activities for the period 6-14 July
1967', 15/286/4(C).
'The cause and mechanism of fatality was
unknown forpemphigus in this period. See
William Boyd, Pathology: structure andfunction,
London, Henry Kimpton, 1970, p. 1407.
9' Examples ofpublications in this period
include: 0 G Bier, M Siqueira, M B Esteves and
P M Freire, 'Quantitative relations in
complement fixation', Am. J. Epidemiol., 1969,
89: 353-7; C Stiffel, A Rerini, H C Passos, 0 G
Bier and G Biozzi, 'R6le de la bourse de fabricius
et du thymus dans la synthese des anticorps
opsonisants', Pathologie du Biologie, 1968, 16:
67-72; E H Beutener, L S Prigenzi, W Hale, C de
A Leme and 0 G Bier, 'Immunofluorescent
studies of autoantibodies to intercellular areas of
epithelia in Brazilian Pemphigusfoliaceus', Proc.
Soc. Exp. Biol. Med, 1968, 127: 81-6; 0 G Bier,
H C Passos and M Siquieria, 'Haemorrhagic
reactions elicited at sites of passive cutaneous
anaphylaxis by the intravenous injection of
aggregated gamma globulin', Immunology, 1968,
14: 291-8.
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The immunology and parasitology sections of the WHO, however, did not find
the Centre's research profile satisfactory. Within months of the Centre's first report
in 1967, Dr N Ansari (Chief, Parasitic Disease, WHO) forwarded to Otto Bier a
copy of P C C Garnham and John Humphrey's review of contemporary problems
in leishmanial immunology.92 Bier's initial response was enthusiastic:
I read with great interest the condensed review of problems in Leishmaniasis related to
immunity ... I am extremely pleased with the initiative taken by the parasitic diseases and
the immunology units ofWHO to put parasitologists and immunologists together in such an
important field as the immunology of Leishmaniasis. Our Center will gladly accept to
participate along the indicated lines in a programme of research to be co-ordinated by WHO
in collaboration with laboratories in different parts of the world.93
Within a few months of this undertaking, however, the future of the Centre had
come under immediate threat. South America had not been immune from the
international student unrest so prominent in 1968. A student strike had led to the
Dean of the host institution being deposed and a considerable re-distribution of
power. As a result, "mere assistant professors [had been] made full professors and
heads ofdepartments".9' Otto Bier had been stripped ofmany of his responsibilities
and both he and his staff had suffered numerous "humiliations".95 Consequently, all
the Centre's staff had either left or were about to leave. Bier suggested, therefore,
that the Centre move with him and a number of the staff to the Butantan Institute
(a biological institute), or that it come under the control of Dr Victor Nussenzweig
in the medical faculty ofthe University ofSao Paulo.96 Howard Goodman was quick
to reply on behalfofthe WHO: whilst they were keen not to rule out the "first rate"
biological institute, they would prefer the Centre to be attached to a medical
department.97 Records of the intermediate events have not survived but, by the
end of 1968, the Assistant Director-General had prepared an agreement for the
"Establishment of the WHO Immunology Research and Training Centre in Sao
Paulo at the Butantan Institute".98 The move received the official blessing of the
Secretary of State for Health' and the agreement was signed on New Year's Eve,
1968.'° Due to the lack of documentary evidence, it is not clear why the Butantan
Institute was chosen. It is likely, however, that the abilities Bier had shown as a
scientist, manager and politician, made his retention as Director of the Centre
preferable. Further, the relocation to a research institute protected the Centre from
the consequences of future student protest.
9 WHO Archive, Letter from Otto Bier to N 98WHO Archive, Letter from A M M Payne
Ansari, 1 April 1968, I5/286/4(C). to 0 G Bier, 2 Dec. 1968, I5/286/4(C).
93 Ibid. 9 The letter urging the move to the Butantan
9'WHO Archive, 'A summarized report on Institute from the "Secretary of State for Health
the occurences at the Escola Paulista de Medicina of Sao Paulo" is discussed in WHO Archive,
and its consequences for WHO immunology Letter from Z Trnka to T DC, 12 Dec. 1968, I5/
research and training center, Sao Paulo, Brazil', 286/4(C).
29 July 1968, I5/286/4(C). '°WHO Archive, Telegram 0 G Bier to H C
95Ibid. Goodman, 31 Dec. 1968, I5/286/4(C).
96Ibd
97WHO Archive, Letter from H C Goodman
to 0 G Bier, 7 Aug. 1968, I5/286/4(C).
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The change of location was accompanied by a change of title with the Centre
being re-named the "Pan American Health Organization/World Health Organization
Immunology Research and Training Center". This was intended to acknowledge the
role the Pan American Health Organization (PAHO) had played in funding the
Centre from early 1967.101 With the opening of the new Centre, and the associated
upheavals, the commitment made by Bier to work on leishmanial immunology
appears to have been forgotten. As a result, research deviated little from its original
programme, with studies of the immunological effects of snake venom and immune
mechanisms in pemphigus dominating.'02
On 5 May 1971, Otto Bier's contract at the Butantan Institute expired.'03 Bier
refused re-appointment to the post of Director of the Centre on the grounds that
he wished to return to bench research:
... what has really determined it is my desire to go back to do bench work while I still feel
like being able to accomplish something in research. On the other hand working in the
laboratory, I will give to the Center an important contribution orientating young members
of the staff and helping to develop them into independent workers.'0"
Further, Bierfreely admitted thathe was "tired ofhaving todealwithbureaucrats".'05
Despite his resignation, his influence was to pervade the future of the laboratory:
not least through his own selection of successor.
Upon announcing the cessation of his contract, Bier immediately suggested that
Ivan Mota, a humoral immunologist working at the Centre, should be appointed to
succeed him. In a letter to the WHO, Bier described Mota as a "shy and reserved
person".'" Such a comment from the verbose and often bullish Bier could be
considered as a criticism. However, Bier was quick to point out that Mota "gets
along very well with the students and with the permanent staffbesides being, as you
know, a very serious and competent worker".'07 Further, he hoped that releasing his
salary would provide sufficient funds for the creation ofa post ofAssociate Director.
To this post he urged the appointment ofthe cellularimmunologist, DrCelso Bianco:
"ourbeststudentin 19689.'08 BiancowasatthistimeworkingwithVictorNussenzweig
at New York University but was expected to return to Brazil by the end of 1971.
By 25 May 1971, Ivan Mota had taken control ofthe Centre"0 and Celso Bianco's
return appeared to have been secured by the offer ofthe post ofHead ofthe Division
of Cellular Immunology at the Butantan Institute."10 With the arrival of a new
101 Bier acknowledges the receipt of $670 from 103WHO Archive, Letter from 0 G Bier to H
the PAHO in WHO Archive, 'Report of activities C Goodman 23 Nov. 1970, 15/286/4(C).
in 1967', I5/286/4(C). " WHO Archive, Letter from 0 G Bier to H
102Four research projects are listed: response C Goodman, 22 Jan. 1971, 15/286/4(C).
ofpatients with Brazilian Pemphigusfoliaceus to 105Ibid.
treatment with azothioprine alone and in 106Ibid.
combination with triamcinolone; complement 107Ibid.
inactivation factor in Bothrops Venom; 108 Ibid.
nephrotoxic activity of lambda 1 and lambda 2 I WHO Archive, Letter from I Mota to G
guinea pig anti-kidney immunoglobulins; fixation Torrigiani (Immunology, WHO), 25 May 1971,
of guinea pig lambda 1 and lambda 2 antibodies 15/286/4(C).
on guinea pig mast cells. WHO Archive, 'PAHO/ 1OWHO Archive, Letter from I Mota to H C
WHO Immunology Research and Training Goodman, 14 Jan. 1972, I5/286/4(C).
Centre at Sao Paulo, Brazil', 15/286/4(C).
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Director, and the impending arrival of Bianco, the WHO were once again quick to
attempt to introduce parasitology into the Centre's research. G Torrigiani of the
WHO immunology section wrote to Bianco and Mota urging them to work on
Chagas' disease:
We are now trying to encourage some research on Chagas' disease. I think that there is still
a lot to be done in this field and I hope it will be easy to obtain support for such activity.
Are you interested in studying the role ofcell-mediated immunity in Chagas when you return
to Sao Paulo? ... We would like very much to interest the Sao Paulo Centre in this activity
and to this end I have already contacted Dr Ivan Mota."'
Mota replied to these promptings by informing Howard Goodman that with the
arrival ofBianco he hoped "to develop with his help an entirely new line ofresearch
in the Center","'2 but that he did not know of anyone interested in working on
Chagas' disease. Bianco's response was more positive, suggesting that he might be
prepared to do so."' Consequently, Mota was again contacted and his collaboration
sought. In response to the interest of Bianco in the subject, Mota replied that he
would be "delighted""4 to collaborate. However, Bianco chose instead to move to
the Rockefeller Institute, New York, and as a result the WHO's hard-won concession
was invalidated."5
The research interests ofthe Centre in 1972 remained very similar to those outlined
in the first report."6 Despite repeated attempts, the WHO had been unable to amend
this research profile in line with their own world health concerns. The position that
Celso Bianco rejected was eventually accepted by W Dias da Silva, an immunologist
specializing in aspects of anaphylaxis and formerly Professor of Immunology at the
University of Belo Horizonte, Brazil.
In 1974, after almost a decade of WHO pressure on the Centre, Mota and Dias
da Silva began research on parasite immunology after receiving a grant of
US$1,700 from the Brazilian National Research Council to study Chagas' disease."17
In the same year the Brazilian Society for Immunology, of which Otto Bier, Dias
da Silva and Motawere all seniormembers,"8 dedicated halfofits second symposium
to the "immunopathology of parasitic diseases with emphasis on Chagas' disease
and schistosomiasis"."19 By the end of 1974, staff at the Centre had prepared and
presented papers on the cross reactivity between the response to Leptomonaspessoai
... WHO Archive, Letter from G Torrigiani to
C Bianco, 23 Dec. 1971, I5/286/4(C).
"'2WHO Archive, Letter from I Mota to H C
Goodman, 14 Jan. 1972, 15/286/4(C).
113WHO Archive, Letter from G Torrigiani to
I Mota, 7 March 1972, I5/286/4(C).
114 WHO Archive, Letter from I Mota to G
Torrigiani, 24 April 1972, 15/286/4(C).
115WHO Archive, Letter from I Mota to G
Torrigiani, 4 Oct. 1972, 15/286/4(C).
"'6WHO Archive, 'Draft brochure prepared
for PAHO', 15/286/4(C). Research interests are
listed as: The mechanism and production of
homocytotropic antibodies in the guinea pig; the
effect of splenectomy and thymectomy on reagin
antibody production; the effect of Bordetella
pertusis vaccine on cell-mediated immunity,
factors present in B. pertussis cells responsible for
their adjuvant effect; studies of the complement
inactivating substances present in the venom of
Bothropsjaracen.
"' WHO Archive, Letter from I Mota to G
Torrigiani, 21 Jan. 1974, I5/286/4(C).
118 In 1972 Otto Bier was President, I Mota
was Secretary and Dias da Silva was First
Secretary of the Brazilian Society for
Immunology. WHO Archive, Report ofActivities
1972, 15/286/4(C).
19WHO Archive, Letter from I Mota to G
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and Trypanosoma cruzi. Associated work at the Centre was in progress on the
reticulo-endothelial system in T cruzi infection in mice, and some collaborative
work with a group working on "experimental Chagas"' at the University of Belo
Horizonte.'20 By 1976, the Centre was offering a special course on the immunology
of Chagas' disease.'2'
The research and training functions of the Centre continued until 1990 when the
agreement between the WHO and the Butantan Institute was terminated.'22 The
activities ofthe Centre remained varied with studies ofantibody production leading
to numerous publications during the 1980s.'23 The Centre was, however, greatly
involvedwithparasite immunology research from themid-1970s onwards, asreflected
in a number of articles on trypanosomal immunology in international journals
such as Clinical and Experimental Immunology and the Scandinavian Journal of
Immunology.'24 The highly collaborative nature ofthese papers shows that the Centre
was influential in South America. The training function of the Laboratory both
through the annual eight-month course, and the special course on Chagas' im-
munology further extended this influence, with students attending from across South
America. Consequently, South American immunology was infused with the public
health concerns of the WHO through the activities of the PAHO/WHO IRTC, Sao
Paulo.
WHO IRTC, Lausanne, Switzerland
The WHO International Reference Centre for Immunoglobulins at the University
of Lausanne was established in 1964.125 Following the death of its founder in 1966,
it was decided to appoint a member of WHO staff to jointly head the Reference
Centre and run an immunology research and training centre there.'26 This decision
was partly made on economic grounds-the Reference Centre was already furnished
with advanced equipment and so it was possible to form an immunology research
and training centre at almost no extra cost. Because of its European location and
its combined Reference Centre/IRTC remit, it was proposed that the Lausanne IRTC
would have a significantly different role to its peripheral counterparts:
the provision of reference services in research on immunoglobulins ...;
exchange of scientific personnel with other Immunology Research and Training Centres and
Immunology Reference Centres for the purposes of research and also refresher training;
120WHO Archive, 'Report of activities in activators ofalternative complement pathway by
1974', I5/286/4(C). immune IgG fragments', Scand. J. Immunol.,
121 WHO Archive, Letter from G Torrigiani to 1985, 22: 217-26. S A Romeiro, H A Takehara
I Mota, 1 Oct. 1976, I5/286/4(C). and I Mota, 'Isotype oflytic antibodies in serum
122WHO Archive, Letter from T Phan Tan to ofChagas' disease patients', Clin. Exp. Immunol.,
Dr A Pelligrini, 25 April 1990, I5/286/4(C). 1984, 55: 413-18.
123 For example, M F Maceda Soares, M S de 125D S Rowe, 'The WHO immunology
Macedo and I Mota, 'Antigenic competition in laboratories at Lausanne', World Health
IgE, IgGI and IgG2 antibody production in the Organization-Chronicle, 1969, 23: 341-4, and
mouse', Int. Arch. Allergy Applied Immunol., WHO Archive, H C Goodman to A M-M Payne
1985, 78: 499-51. (Assistant Director-General, WHO), 12 Jan. 1967,
124 For example, T L Kipnis, A U Krettli and 15/286/4(C).
W Dias da Silva, 'Transformations in 126 WHO Archive, Memo H C Goodman to A
trypomastigote forms of Trypanosoma cruzi into M-M Payne, 12 Jan. 1967, I5/286/4(B).
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the collection, exchange and distribution ofimmunological reagents which are rare or difficult
to obtain or produce (antigens-antisera);
the organization of specialized courses in immunological techniques;
annual meetings of investigators and researchers on the use of human immunoglobulins
(supported by an NIH grant);
and thehandling ofproblems arisingunexpectedly inthefield ofimmunoglobulins (anexample
is the anti-D antibody in prevention ofhaemolytic disease ofthe newborn).'27
The Lausanne IRTC was, therefore, to be concerned primarily with the supply, use
and study of immunoglobulins. Its location limited the value of annual research
courses such as those at Sao Paulo and Ibadan, as similar basic immunology courses
were already available throughout Europe. The training function of the IRTC was
instead to be met by the provision of highly specialized short courses and of longer
term research facilities for semi-established scientists from developing countries.'28
The post at Lausanne was created with David S Rowe, a humoral immunologist
in Philip Gell's Birmingham University research group, already "lined up for the
job".'29 By May 1967, Rowe had accepted the post of "Chief Scientist (Im-
munologist)".'30 Undaunted by his newly acquired administrative and managerial
responsibilities, Rowe embarked on a dynamic programme of research. Between
1968 and the end of 1970 he published 34 articles injournals such as Nature, Bulletin
of the World Health Organization, Clinical and Experimental Immunology, New
England Journal ofMedicine and Journal ofImmunology.'3' His research interests in
this period were dominated by antibody studies with publications concerning
IgA,'32 IgD,'33 IgE,'34 IgG,'35 and IgM'36 as well as a number of immunoglobulin
surveys.'37
Despite Rowe's heavy involvement in research, his administrative and training
commitments appear to have been fulfilled. By October of 1969 the Centre had
trained visitors from Uganda, Iran, Kenya, Czechoslovakia, Romania, Hungary and
127 Ibid.
128 For example, a short course on lymphoidal
cell function was held in September 1969. D S
Rowe, 'The WHO immunology laboratory',
World Health Organization Chronicle, 1969, 23:
342.
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M Stella and D S Rowe, 'Secretory IgA in
human serum', J. Immunol., 1970, 105: 43-7.
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1 For example, D S Rowe and C B Wood,
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asthma', Int. Arch. Allergy Applied ImmunoL,
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arthritis', Clin. Exp. Immunol., 1969, 4:
537-53.
"'1 For example, I A McGregor, D S Rowe, M
E Wilson and W Z Bllewicz, 'Plasma
immunoglobulin concentrations in an African
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malaria and other infections and pregnancy',
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Senegal.'38 Regardless ofthe apparent success ofthese early years and the correlation
between the research profile of the IRTC and the responsibilities of the Reference
Centre, the WHO wanted a change of direction.
In March 1968, Howard Goodman wrote to John Humphrey at the National
Institute for Medical Research, UK, to enquire whether a British group might be
interested in working on the problems ofimmunity to leishmaniasis. Goodman went
on to explain that if it were not possible to initiate sufficient research in Britain he
hoped that a leishmania project could be developed at Lausanne.'39 Humphrey's
reply has not been retained. However, six months later David Rowe had secured
approval for Wellcome Trust funding at the Lausanne Centre."4 The highly inter-
national nature of the laboratory justified funding for an institution so far outside
the geographical remit of the Wellcome Trust:
the special position of ... [the] immunological research and training centre in Lausanne in
relation to other parts ofthe world provided the trustees with sufficientjustification to support
fundamental laboratory work in a country other than Britain, and an exception was therefore
made.'4'
The nature ofthis "special position" is not elaborated and it may refer either to the
advanced facilities owned by the laboratory or the Centre's accessibility for training
people from all over the world.
On New Year's Eve 1969, A M-M Payne, Assistant Director-General ofthe WHO,
submitted an 'Application to the Wellcome Trust for Research on Immunological
Mechanisms Operative in Tropical Disease'.'42 Five years' funding was requested for
the formation of a parasite immunology research group at the Lausanne Centre.'43
The application was the product of an official policy change on the part of the
WHO. Following the success ofthe application, D S Rowe wrote to J Mauel, a viral
and cellular immunologist at the Wistar Institute, Philadelphia, in an attempt to
recruit him to the post of Wellcome Senior Research Fellow. In his letter, Rowe
described the recent policy changes. It had now been "decided to broaden the
interests of the WHO laboratory to essentially that of a laboratory of immunology
related to the needs and interests of the WHO".'" In future, the Centre was to
concentrate on "basic research"'45 and training in parasite immunology-especially
leishmaniasis. The choice ofthis particular disease was based largely on the fact that
a suitable model existed in the guinea pig and so the temperate location of the
laboratory presented little inconvenience.'"
138 WHO Archive, Memo H C Goodman to 142 WHO Archive, Welcome Trust grant
Assistant Director-General and Director-General, application signed A M-M Payne, 31 Dec. 1969,
19 Sept. 1969, I5/286/4(B). I5/286/4(B).
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With the appointment ofMauel to the post, the laboratory gained an experienced
immunologist. However, parasitological knowledge was lacking amongst the staff.
To remedy this, an Iranian parasitologist, Dr R Behin, was appointed to "provide
the technical background in parasitology".'47 The addition of a further technician
completed the "Leishmaniasis Group".148 Despite the founding of the new group,
research at the Centre continued largely as it had since the 1960s. In the first three
months of 1971 projects on the immune system in the respiratory tract and the
immunoglobulins secreted by, and attached to, lymphocytes continued concurrently
with the leishmania and immunoglobulin reference work.'49
In February 1972, the Leishmania Group was expanded with the arrival of Dr
Biroum-Noerjasin on a WHO fellowship during which he was to gain knowledge of
cellular immunology.'50 In the following year, the parasitological emphasis of the
Centre was increased with the arrival of the veterinary parasitologist and im-
munologist Dr J J Doyle funded by the Wellcome Trust to research into the
relationship between parasite antigens and immunity.'5' Around the same time, Dr
G I Pardoe, an immunochemist from the Birmingham group, began a research
project at the Centre that included studies of the immunochemistry of parasite
antigens.'52 This coincided with the arrival of Dr A S Ghose, a WHO fellow from
India who came for one year's research in leishmanial immunology, thus completing
the expansion ofthe parasitology group."' By 1974, ofthe seven researchers working
at the Centre, only David Rowe retained an interest in immunoglobulin studies.
DoctorsPardoe, Mauel, Behin, Biroum-Noerjasin, DoyleandGhosewereallinvolved
instudiesofparasiteimmunology.'54Theparasitologicalemphasiswasfurthersecured
in that year by the award ofa grant from the agricultural division ofthe Rockefeller
Foundation for work on antigenic variation in Trypanosoma brucei."' The Wellcome
Trust funding was also extended for a further year although this fell considerably
short ofthe grant requested.'56 This change ofresearch interests was reflected in the
teaching at the Centre, with the 1973 and 1974 courses being concerned with the
"Immunology of Infectious Diseases". 57 The 1973 course was attended by sixteen
students and four observers representing a total of nineteen different countries.
Between 1967 and 1974 the WHO created, through deliberate policies, a parasite
immunology centre at the University of Lausanne. Whilst the IRTC was based
within the Immunoglobulin Reference Centre and originally followed a successful
research programme associated with these reference functions, the development of
cellular studies of leishmaniasis was heavily promoted. Influenced by this new
147 Ibid. '54WHO Archive, 'Quarterly field report', 5
Ibid. Jan. 1974, 15/286/4(B).
WHO Archive, 'Quarterly field report', 20 '5 WHO Archive, Letter from J J McKelvey
April 1971, 15/286/4(B). (Associate Director, Agricultural Sciences,
"' WHO Archive, 'Quarterly field report', Jan. Rockefeller Foundation) to D S Rowe, 15 March
to March 1972, 15/286/4(B). 1974, I5/286/4(B).
"' WHO Archive, 'Quarterly field report', 1 156WHO Archive, Letter from B E C
April to 30 June 1973, I5/286/4(B). Hopwood (Director, Wellcome Trust) to D S
152WHO Archive, 'Quarterly field report', 1 Rowe, 17 May 1974, 15/286/4(B).
Jan. to 31 March 1973, I5/286/4(B). 157WHO Archive, 'Quarterly field report' 30
'53WHO Archive, 'Quarterly field report', 30 Sept. 1973 and 16 Oct. 1974, I5/286/4(B).
Sept. 1973, I5/286/4(B).
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research profile, the training function of the laboratory was changed, with visiting
researchers from developing countries being involved in the parasitologically based
research programme. The taught courses given by the Centre also changed sig-
nificantly, providing training in the immunology of infectious diseases after 1973.
Conclusions:
The WHO and Immunology 1964 to 1974
By 1973, WHO Immunology Research and Training Centres were operational in
Nairobi, Singapore, New Delhi, Lausanne, Beirut, Mexico City, Sao Paulo, Ibadan,
Rehovoth, Basel and Melbourne.'58 This paper has provided a case study of only
three of these Centres. In spite of existing differences in budget, structure and local
traditions between the disparate Centres, the role of the WHO in the academic
direction of all three institutions remained consistent. Further, the immunology of
parasitic diseases can be shown to have been a considerable component of the
research programme at Rehovoth, Nairobi, and New Delhi as well as at the three
Centres examined.
The original structure outlined for the IRTCs in the report of the five Scientific
Groups on Immunology in 1964 involved the transfer of both junior and senior
Western staff to developing countries.'59 Of the three laboratories examined here,
only Ibadan relied upon the importation of such skilled scientists and was in a few
years able to provide a "local" staff. Such an approach was inappropriate for the
Swiss laboratory and unnecessary in Brazil where a small but advanced group of
immunologists was already functioning. In fact, contrary to the assumed transfer of
Western skills to the scientific periphery, the Lausanne laboratory relied on Iran for
the provision of a competent parasitologist to facilitate their research programme.
The assumption by the Scientific Group that the transplantation ofWestern scientists
into Asia, Africa and South America would be required to stimulate the local
formation of a professional discipline of immunology may have resulted from a
failure to recognize that such a group existed in a limited form already. This
misunderstanding was perhaps caused by the Western dominance of the committee
that made the recommendations. The members of this group represented America,
Australia, France and South Africa only. Interestingly, African and South American
representatives were invited to attend another meeting in this series.'60
The Sao Paulo Centre was staffed by South Americans and within a few years of
its opening was able to invite numerous visiting consultants from elsewhere in the
continent to teach and research at the Centre.'6' This suggests the presence of a
158 WHO Archive, Circular by H C Goodman Willy Becak (Butantan Institute, Salo Paulo), Otto
to IRTCs, 28 March 1973, I5/286/4(A). G Bier (Department of Public Health, Salo
'19Research in immunology, op. cit., note 25 Paulo), Guido Biozzi (Broussais Hospital, Paris),
above, p. 79. M Carnargo (Medical School, Sao Paulo), C
" Otto Bier (Brazil) and J C Edozien Fava Neto (Medical School, Sao Paulo), R G
(Nigeria) were members of the Scientific Group Ferri (Medical School, Sao Paulo), S F Lara
on Immunochemistry. Research in immunology, (Biochemistry, Sao Paulo), C Moreno (Chemistry
op. cit., note 25 above, p. 79. and Pharmacy, University ofChile), S Leal Prado
161 The following were visiting Professors or (Paulista School of Medicine, Sao Paulo), L S
Guest Lecturers at the Salo Paulo Centre in 1971: Prigenzi (Campinas State University, Silo Paulo),
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pre-existing immunological tradition within that continent. However, the research
programme upon which the Sao Paulo Centre originally embarked was devoid of
local concerns. Instead, the immunochemical and mechanistic interests of con-
temporary North American immunologists were allowed to dominate, possibly
because South American immunologists had already been trained inNorthAmerican
institutes. It would appear that the eventual role of the WHO in Brazil was the re-
orientation of the embryonic local discipline to include studies of local infections
such as Chagas' disease. The failure of the WHO to achieve this goal for almost a
decade-even within its own Research and Training Centre-was a product both of
Otto Bier's dominating personality, and ofthe fact that the WHO provided less than
20 per cent of the Centre's income.162
The success of the training programme of the Ibadan laboratory was recognized
as limited despite the supervision of a number of doctoral students. The annual
course was poorly attended and rarely attracted candidates from outside Nigeria.
Consequently, as Houba himself admitted, the influence of the Centre on African
science was distinctly limited. The research function ofthe laboratory was, however,
considerably more successful. Whilst the prestigious publications outlined earlier
were important in this, I would argue that the highly international nature of the
collaborative projects undertaken was possibly even more important. These projects
included such important figures as Tony Allison (NIMR, UK), John Soothill (Great
Ormond Street Hospital, UK) and David Rowe (WHO IRTC, Lausanne).163 These
contacts, combined with the numerous consultants such as A J S Davies (Chester
Beatty Institute, UK) and C S Henney (Department of Medicine, Johns Hopkins
School ofMedicine, USA), placed the Ibadan Centre at the fulcrum of a worldwide
network ofimmunology. Some of these actors were to play a significant role in the
development ofparasite immunology in other continents. For example, Tony Allison
co-founded andeditedthejournal ParasiteImmunology, whilstAJ S Daviespublished
many associated papers. Although the local success of this Centre may well have
been limited, its international significance seems to have been great. Despite the
achievements, frustration at the limits ofthe training programme ofthe Centre was
a precipitating factor in the withdrawal of WHO staff in 1972, and the transfer of
the laboratory to the control of the University of Ibadan.
Deliberate attempts were made by the WHO to further the international influence
ofthe WHO IRTCs. On one occasion, Vashek Houba was funded to present a paper
W Dias da Silva (Medical School, Belo American Health Organization and the Escola
Horizonte), M Siqueria (Paulista School of Paulista. WHO Archive, 'WHO IRTC, Sao
Medicine, Sao Paulo), A Strauss (Medical School, Paulo, Brazil: Report of activities in 1967 and
Sao Paulo), A Szenberg (Walter and Eliza Hall plans for 1968', 15/286/4(C).
Institute of Medical Research, Melbourne), 163Also R Hendrickse (University College
Professor N Vaz (Medical School, Niteroi Federal Hospital, Ibadan, Nigeria), Professor Desmonde
University, Rio de Janeiro). (Pasteur Institute, Dakar), I A McGregor
162In 1967, the WHO provided the Sao Paulo (Medical Research Council Laboratories,
Centre with US$7,500 which is approximately Gambia) and G Binz (WHO Trypanosomiasis
16.6 per cent of the total of US$45,930 received Project, Kenya).
in income that year. Other sources were the Pan
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on malarial nephritis at a British Society for Immunology meeting in London.'" A
couple of years later Howard Goodman arranged a session titled 'Practical and
potential contributions of immunology to the problems of developing countries' at
the Second International Congress of Immunology.'65 The session was introduced
and chaired by John Humphrey in Niels Jerne's absence, and consisted ofpapers by
present and former Directors of four IRTCs as well as an introductory paper by
HowardGoodman.'66 Thepromotion oftheWHO'simmunologicalresearchinterests,
especially parasite immunology, was clearly the aim of this session. Goodman was
convinced it had been successful in this respect, writing in the official report that he
was "sure we made many recruits among the younger scientists who are interested
in participating in this programme".167
Another mechanism through which the IRTCs exerted their influence was inter-
action with immunological societies. The Brazilian Society for Immunology was
formed at the twenty-fourth meeting ofthe Brazilian Society for the Advancement of
Sciences, following "ameetingofimmunologists andpeopleinterestedinimmunology
under the auspices of[the Sao Paulo] ... IRTC".'68 The new organization was based
at the Sao Paulo Centre and its committee was heavily dominated by present and
former staff members,'69 which testifies to the considerable influence of the WHO
IRTC in Brazilian immunology. The numbers of South American visitors, coupled
withthedominance ofSouth Americanconsultants tothe annual course, demonstrate
the degree to which the Brazilian Centre was an important locus in a South American
network. The activities ofthe Brazilian Society were accordingly influenced by WHO
concerns, with half of their second meeting being dedicated to parasitic disease. An
immunology society was also founded within the Ibadan IRTC by Dr Salimonu, the
centre's African technician.'70 Appropriately, the inaugural lecture ofthis group was
given by Howard Goodman who spoke on 'The role of WHO in immunology
research and training'.'71
The funding and operation of the World Health Organization IRTCs can be
considered to have been an attempt to promote interaction between the disciplines
of parasitology and immunology. Although formed initially as centres for training
164Houba spoke at a BSI meeting in October
1970 at London. WHO Archive, 'Quarterly field
report', July to Sept. 1970, I5/28614(A).
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India and her neighbours' by G P Talwar; 'Some
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in general immunology, all three institutions in these case studies were rapidly
transformed into parasite immunology research and training centres. This trans-
formation can be seen to have been enforced despite considerable inertia from
scientists loyal to more mainstream immunology research programmes. Whilst it is
difficult to quantify the influence of the IRTCs, it is clear that the short-term
consultancy system coupled with conference presentations, collaborative ventures
and publication of material, contributed to the international dissemination of the
research interests ofthe WHO. The direct effect of these activities on the disciplines
ofimmunology and parasitology is unquantifiable. However, the involvement in this
programme of highly regarded immunologists from across Europe and America
infused immunology with a growing awareness of parasitological problems ap-
propriate for investigation. A number ofWestern scientists who were involved with
the Centres went on themselves to become influential parasite immunologists.
The WHO IRTCs therefore form an important chapter in the history of the
internationalization ofendeavours to apply immunological knowledge and practices
to parasitic diseases. Further, this programme was an important precursor to the
much broader and more influential WHO tropical diseases research and training
programme which was also headed by Howard Goodman.
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